Literature DB >> 25746104

Multifaceted Modulation of SIRT1 in Cancer and Inflammation.

Hui Yang1, Yujing Bi2, Lixiang Xue3, Jian Wang1, Yun Lu1, Zhengguo Zhang1, Xi Chen1, Yiwei Chu1, Ruifu Yang2, Ruoning Wang4, Guangwei Liu1.   

Abstract

SIRT1 is a highly conserved NAD+-dependent protein deacetylase that is involved in diverse cellular processes. SIRT1 can deacetylate not only histones, but also a growing number of nonhistone substrates involved in multiple signaling pathways. Accumulating evidence has indicated that SIRT1 is a key regulator of life span extension, DNA damage, metabolism stress, inflammation, and cancer. In inflammation, SIRT1 deacetylates several transcription factors and regulates the immune cell responses. In cancer, recent discoveries revealed opposite effects of SIRT1 as an oncoprotein or a tumor suppressor under different conditions. In the tumor microenvironment, both infiltrated immune cells and cancer cells can be affected by SIRT1. Understanding the proper cancer-related functions of SIRT1 in both systems may provide potential evidence for SIRT1-based therapies. Here, we discuss the current understanding of SIRT1 in regulating immune responses and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25746104     DOI: 10.1615/critrevoncog.2014012374

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  42 in total

Review 1.  Lipid Metabolism in Tumor-Associated Macrophages.

Authors:  Yuancai Xiang; Hongming Miao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Chronic Silymarin, Quercetin and Naringenin Treatments Increase Monoamines Synthesis and Hippocampal Sirt1 Levels Improving Cognition in Aged Rats.

Authors:  F Sarubbo; M R Ramis; C Kienzer; S Aparicio; S Esteban; A Miralles; D Moranta
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-14       Impact factor: 4.147

3.  The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2.

Authors:  Dipon Das; Nathan Smith; Xu Wang; Iain M Morgan
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

4.  SIRT1 was involved in TNF-α-promoted osteogenic differentiation of human DPSCs through Wnt/β-catenin signal.

Authors:  Guijuan Feng; Ke Zheng; Donghui Song; Ke Xu; Dan Huang; Ye Zhang; Peipei Cao; Shuling Shen; Jinlong Zhang; Xingmei Feng; Dongmei Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-08-16       Impact factor: 2.416

5.  Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.

Authors:  Shulin Xiang; Robert T Dauchy; Aaron E Hoffman; David Pointer; Tripp Frasch; David E Blask; Steven M Hill
Journal:  J Pineal Res       Date:  2019-06-09       Impact factor: 13.007

6.  Targeting the IL-9 pathway in cancer immunotherapy.

Authors:  Ningbo Zheng; Yong Lu
Journal:  Hum Vaccin Immunother       Date:  2020-02-10       Impact factor: 3.452

7.  Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.

Authors:  Quan Hong; Lu Zhang; Bhaskar Das; Zhengzhe Li; Bohan Liu; Guangyan Cai; Xiangmei Chen; Peter Y Chuang; John Cijiang He; Kyung Lee
Journal:  Kidney Int       Date:  2018-02-22       Impact factor: 10.612

8.  Metformin acts to suppress β-hydroxybutyric acid-mediated inflammatory responses through activation of AMPK signaling in bovine hepatocytes.

Authors:  Tianle Xu; Xubin Lu; Abdelaziz Adam Idriss Arbab; Xinyue Wu; Yongjiang Mao; Juan J Loor; Zhangping Yang
Journal:  J Anim Sci       Date:  2021-07-01       Impact factor: 3.159

9.  SIRT1 Gene SNP rs932658 Is Associated With Medication-Related Osteonecrosis of the Jaw.

Authors:  Guang Yang; Joseph M Collins; Roya Rafiee; Sonal Singh; Taimour Langaee; Caitrin W McDonough; L Shannon Holliday; Danxin Wang; Jatinder K Lamba; Young Sick Kim; Gian Andrea Pelliccioni; Mihaly Vaszilko; Janos P Kosa; Bernadett Balla; Peter A Lakatos; Joseph Katz; Jan Moreb; Yan Gong
Journal:  J Bone Miner Res       Date:  2020-10-23       Impact factor: 6.741

10.  SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1.

Authors:  Jun Zhou; Ming Xu; Kehao Le; Jie Ming; Hui Guo; Shengnan Ruan; Tao Huang
Journal:  Onco Targets Ther       Date:  2020-05-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.